Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.99
HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2024 results: revenue $999.6 million, net income $55.7 million, EPS $0.64 per diluted share.
- Period
- the fiscal year ended January 31, 2024
- Revenue
- $999.6 million
- Net income
- $55.7 million
- EPS
- $0.64 per diluted share
- Result
- reported results
Exact text from the filing
--- EX-99.1 (EX-99.1) --- HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results Highlights of the fiscal year include: • Revenue of $999.6 million, an increase of 16% compared to $861.7 million in FY23. • Net income of $55.7 million, compared to net loss of $26.1 million in FY23, with non-GAAP net income of $195.5 million,
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.99
HEALTHEQUITY, INC. reported the fourth quarter ended January 31, 2024 results: revenue $262.4 million, net income $26.4 million, EPS $0.30 per diluted share.
- Period
- the fourth quarter ended January 31, 2024
- Revenue
- $262.4 million
- Net income
- $26.4 million
- EPS
- $0.30 per diluted share
- Result
- reported results
Exact text from the filing
Revenue for the fourth quarter ended January 31, 2024 was $262.4 million
View on SEC.gov